Cepheid MTB/RIF Assay

The Florida Department of Health's Bureau of Public Health Laboratories (BPHL) is seeking to acquire Cepheid Xpert MTB/RIF assay kits to enhance their diagnostic capabilities for tuberculosis. The assay, identified as Cepheid Cat. No. GMTB/RIF-US-10, is designed for rapid detection of Mycobacterium tuberculosis complex and Rifampin resistance through a semi-quantitative nested real-time PCR process. This testing is critical for identifying TB infections and associated drug resistance in sputum samples, particularly among patients at risk for Rifampin resistance. The department intends to purchase these assay kits as a single source, in accordance with Florida Administrative Code 60A-1.045, to ensure compatibility with their existing Cepheid GeneXpert system and testing algorithm. The solicitation, titled "Cepheid MTB/RIF Assay," was posted on September 12, 2025, with a response deadline of October 3, 2025. The contract is valued between $500,000 and $1,500,000 and is managed by the Florida Department of Health. Interested vendors can contact Summer Lindsley via email or phone for further details. The procurement aims to streamline TB testing processes, improve diagnostic accuracy, and support public health efforts in managing tuberculosis cases within the state of Florida. More information about the solicitation can be accessed through the Florida Vendor Marketplace.